- Corporate Officers - T
- Tsuchimoto Kim R
Insider Trading History of Tsuchimoto Kim R
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Tsuchimoto Kim R since 2007.
This trader's CIK number is 1333516.
At the time of last reporting, Tsuchimoto Kim R was the Chief Financial Officer of Monopar Therapeutics. (stock ticker symbol MNPR).
Also see all insider trading activities at Monopar Therapeutics.
Note that in the past
Tsuchimoto Kim R also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Raptor Pharmaceuticals Corp. (RPTP) by Tsuchimoto Kim R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | RPTP | 0 | $0 | 0 | $0 | 2,500 | $1,500 |
Yearly summary of insider trading at Axonyx Inc (RPTP) by Tsuchimoto Kim R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | RPTP | 0 | $0 | 14,236 | $87,400 | 14,236 | $36,583 |
Yearly summary of insider trading at Monopar Therapeutics (MNPR) by Tsuchimoto Kim R
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | MNPR | 0 | $0 | 0 | $0 | 31,101 | $0 |
| 2023 | MNPR | 0 | $0 | 0 | $0 | 36,166 | $0 |
| 2022 | MNPR | 0 | $0 | 0 | $0 | 17,652 | $0 |
| 2021 | MNPR | 0 | $0 | 0 | $0 | 4,894 | $0 |
| 2019 | MNPR | 325 | $2,600 | 0 | $0 | 0 | $0 |
Insider trading activities at 3 companies by Tsuchimoto Kim R:
1. Raptor Pharmaceuticals Corp. (RPTP)
2. Axonyx Inc (RPTP)
3. Monopar Therapeutics (MNPR)
Table 1. Insider trading of Raptor Pharmaceuticals Corp. (RPTP) by Tsuchimoto Kim R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-05-17 | RPTP | Option Ex | 2,500 | .60 | 1,500 |
Table 2. Insider trading of Axonyx Inc (RPTP) by Tsuchimoto Kim R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-08-29 | RPTP | Option Ex | 3,510 | 2.57 | 9,020 |
| 2012-08-29 | RPTP | Sale | 3,510 | 5.00 | 17,550 |
| 2012-08-27 | RPTP | Option Ex | 49 | 2.57 | 125 |
| 2012-08-27 | RPTP | Sale | 49 | 5.00 | 245 |
| 2012-06-15 | RPTP | Sale | 3,559 | 5.77 | 20,528 |
| 2012-06-15 | RPTP | Option Ex | 3,559 | 2.57 | 9,146 |
| 2012-04-16 | RPTP | Option Ex | 3,559 | 2.57 | 9,146 |
| 2012-04-16 | RPTP | Sale | 3,559 | 6.05 | 21,531 |
| 2012-02-15 | RPTP | Option Ex | 3,559 | 2.57 | 9,146 |
| 2012-02-15 | RPTP | Sale | 3,559 | 7.74 | 27,546 |
Table 3. Insider trading of Monopar Therapeutics (MNPR) by Tsuchimoto Kim R
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-06-30 | MNPR | Option Ex | 9,957 | .00 | 0 |
| 2024-03-31 | MNPR | Option Ex | 9,956 | .00 | 0 |
| 2023-12-31 | MNPR | Option Ex | 9,957 | .00 | 0 |
| 2024-01-01 | MNPR | Option Ex | 1,231 | .00 | 0 |
| 2023-09-30 | MNPR | Option Ex | 9,956 | .00 | 0 |
| 2023-06-30 | MNPR | Option Ex | 14,846 | .00 | 0 |
| 2023-03-31 | MNPR | Option Ex | 5,067 | .00 | 0 |
| 2022-12-31 | MNPR | Option Ex | 5,067 | .00 | 0 |
| 2023-01-01 | MNPR | Option Ex | 1,230 | .00 | 0 |
| 2022-09-30 | MNPR | Option Ex | 5,066 | .00 | 0 |
| 2022-06-30 | MNPR | Option Ex | 8,913 | .00 | 0 |
| 2022-03-31 | MNPR | Option Ex | 1,221 | .00 | 0 |
| 2021-12-31 | MNPR | Option Ex | 1,221 | .00 | 0 |
| 2022-01-01 | MNPR | Option Ex | 1,231 | .00 | 0 |
| 2021-09-30 | MNPR | Option Ex | 1,221 | .00 | 0 |
| 2021-06-30 | MNPR | Option Ex | 2,442 | .00 | 0 |
| 2021-01-01 | MNPR | Option Ex | 1,231 | .00 | 0 |
| 2019-12-18 | MNPR | Buy | 325 | 8.00 | 2,600 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Tsuchimoto Kim R
(Chief Financial Officer of Monopar Therapeutics at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.